… As Expert says no country is safe until all are COVID-19 free***
Nigeria has announced additional 206 new COVID-19 cases in the country as total infections from the virus rise to 169,884 as of July 20, 2021.
The Nigeria Centre for Disease Control (NCDC) made this known on its official website handle on Wednesday morning.
The newsmen report that the new infections indicate an increase from the 146 cases announced a day earlier.
It noted that there was no COVID-19 related death on Tuesday while the country’s total fatality stood at 2,128.
The agency disclosed that 23 people who had recovered from the disease were discharged from isolation centres across the country.
The NCDC added that till date, 164,733 recoveries were recorded nationwide in 36 states and the Federal Capital Territory.
It added that the nation’s active cases stood at 2,286.
The NCDC added that the 206 were reported in 10 states: Lagos – 132; Akwa Ibom – 56; Ekiti – 5; Delta – 3; Rivers – 2; Enugu – 2; Jigawa – 2; Katsina – 2; Gombe – 1 and the FCT – 1.
The Public Health agency noted that “today’s report includes zero cases from Plateau, Sokoto, Kano, Oyo, Ondo, Osun, Nasarawa and Kaduna States.”
The NCDC noted that there were, however, more than 3,301 cases that were still active in the country.
The agency said that the country had also tested more than 2.4 million samples for the virus out of the country’s roughly 200 million population.
The NCDC added that a multi-sectoral national emergency operations centre (EOC), activated at Level 2, had continued to coordinate the national response activities.
In the meantime, Prof. Olanike Adeyemo on Tuesday in Ibadan said that collaboration instead of competition in vaccine distribution, tests, and treatments would be an important strategy toward ending the global COVID-19 pandemic.
Adeyemo of the Department of Veterinary Public Health and Preventive Medicine, University of Ibadan, stated this in an interview with the newsmen.
According to her, no country is safe until everyone in that country is COVID-19 free.
She said that the pledge by G7 leaders in Cornwall to work toward vaccine equity would mean nothing if countries of the world did not have a strategy that would recognise an integrated approach to health care.
“In fact, when the WHO called on countries to work together for vaccine equity in January 2021, the aim was to ensure access to the vaccine across the continent.
“A second call in May, when the WHO called for 20 million doses of COVID-19 highlighted the growing gap.
“According to the Centre for Disease Control, CDC, about 35 per cent of Americans had been fully vaccinated by early May compare to Africa where only 1.12 per cent have received at least one dose,” she said.
Adeyemo said that invisible to the calls was the underlying principle that vaccine equity needed a one- health approach.
“Collaboration, instead of competition, is needed to enhance synergies of various sectors in improving healthcare standard.
“COVID-19 vaccine equity means that everyone, everywhere should have access to the vaccines as quickly as possible, starting with those at highest risk of serious disease or death,” she said.
According to Adeyemo, although there is a global alliance for fair and equitable vaccine distribution, COVID-19 vaccines are developed by pharmaceuticals and organisations, who are in business for profit.
“COVAX is working to accelerate the development and the manufacturing of COVID-19 vaccines and ensure that there is fair and equitable access to these vaccines for all countries.
“However, the availability of COVID-19 vaccines, does not necessarily translate to access for most countries classified as developing economies, who do not have the financial capabilities to purchase enough vaccines for their citizens.
“COVAX facility was expected to deliver no less than 90million doses of COVID-19 vaccines to Africa in the first quarter of 2021 and 2billion by the end of the year. However, the quantity allocated to the region is inadequate considering the population of people on the continent.
“To date, Nigeria has received nearly 4million doses of the AstraZeneca/Oxford COVID-19 vaccine via the COVAX Facility, “she said.